A new class of DNA alkylating indolino-benzodiazepine agents (BIAs) linked with a DNA binding moiety for use with antibody-drug conjugates (ADCs)

被引:0
|
作者
Miller, Michael L. [1 ]
Reid, Emily E. [1 ]
Archer, Katie E. [1 ]
Shizuka, Manami [1 ]
McShea, Molly A. [1 ]
Maloney, Erin K. [1 ]
Ab, Olga [1 ]
Lanieri, Leanne [1 ]
Wilhelm, Alan J. [1 ]
Ponte, Jose F. [1 ]
Yoder, Nicholas C. [1 ]
Chari, Ravi V. [1 ]
机构
[1] ImmunoGen Inc, Waltham, MA USA
关键词
D O I
10.1158/1538-7445.AM2018-747
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
747
引用
收藏
页数:2
相关论文
共 35 条
  • [21] On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency
    Igor Dovgan
    Anthony Ehkirch
    Victor Lehot
    Isabelle Kuhn
    Oleksandr Koniev
    Sergii Kolodych
    Alexandre Hentz
    Manon Ripoll
    Sylvain Ursuegui
    Marc Nothisen
    Sarah Cianférani
    Alain Wagner
    Scientific Reports, 10
  • [22] On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency
    Dovgan, Igor
    Ehkirch, Anthony
    Lehot, Victor
    Kuhn, Isabelle
    Koniev, Oleksandr
    Kolodych, Sergii
    Hentz, Alexandre
    Ripoll, Manon
    Ursuegui, Sylvain
    Nothisen, Marc
    Cianferani, Sarah
    Wagner, Alain
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Antibody-Drug Conjugates (ADCs) with novel IGN DNA-alkylating agents display potent antigen-specific activity against hematologic and solid tumor xenograft models.
    Whiteman, Kathleen
    Johnson, Holly
    Wilhelm, Alan
    Miller, Michael
    Li, Wei
    Reid, Emily
    Archer, Katie
    Fishkin, Nathan
    Dandeneau, Andre
    Maloney, Erin
    Pinkas, Jan
    Chari, Ravi
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [24] Antibody-drug conjugates (ADCs) with indolinobenzodiazepine dimer (IGN) payloads: DNA-binding mechanism of IGN catabolites in target cancer cells
    Singh, Rajeeva
    Harris, Luke
    Salomon, Paulin
    Reid, Emily E.
    Miller, Michael L.
    Chari, Ravi V.
    Keating, Thomas A.
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Antibody-drug conjugates (ADCs) with a novel DNA-alkylating agent, DGN462, are highly potent in vitro and in vivo against human cancer models
    Whiteman, Kathleen
    Audette, Charlene
    Dandeneau, Andre
    Ellis, Megan
    Fishkin, Nathan
    Harvey, Lauren
    Johnson, Holly
    Kovtun, Yelena
    Maloney, Erin
    Miller, Michael
    Wilhelm, Alan
    Chari, Ravi
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Design, synthesis and evaluation of a novel DNA-interactive agent: A promising new class of cytotoxic molecules for use in antibody-drug conjugates
    Li, Wei
    Fishkin, Nathan E.
    Miller, Michael
    Leece, Barbara
    Reid, Emily
    Archer, Katie
    Maloney, Erin
    Jones, Gregory
    Kovtun, Yelena
    Singh, Rajeeva
    Chari, Ravi V. J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [27] A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs)
    Miller, Michael L.
    Shizuka, Manami
    Wilhelm, Alan
    Salomon, Paulin
    Reid, Emily E.
    Lanieri, Leanne
    Sikka, Surina
    Maloney, Erin K.
    Harvey, Lauren
    Qiu, Qifeng
    Archer, Katie E.
    Bai, Chen
    Vitharana, Dilrukshi
    Harris, Luke
    Singh, Rajeeva
    Ponte, Jose F.
    Yoder, Nicholas C.
    Kovtun, Yelena
    Lai, Katharine C.
    Ab, Olga
    Pinkas, Jan
    Keating, Thomas A.
    Chari, Ravi V. J.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (03) : 650 - 660
  • [28] Human antibody conjugates of DNA minor groove-binding alkylating agents with single dose efficacy in xenograft models which retain activity in drug resistant cells
    Pan, Chin
    Gangwar, Sanjeev
    Chen, Liang
    Rao, Chetana
    Huber, Mary
    Sattari, Peter
    Do, Mary
    Dai, Rory
    Chong, Colin
    Soderberg, Carol
    Li, Hao
    Sufi, Bilal
    Boyd, Sharon
    Huang, Haichun
    Chen, Haibin
    Guerlavais, Vincent
    Horgan, Killian
    Sharkov, Nik
    Cardarelli, Pina
    King, David J.
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Antibody-Drug Conjugates with Indolinobenzodiazepine Dimer Payloads: DNA-Binding Mechanism of indolinobenzodiazepine Dimer Catabolites in Target Cancer Cells
    Singh, Rajeeva
    Reid, Emily E.
    Harris, Luke
    Salomon, Paulin L.
    Miller, Michael L.
    Chari, Ravi V. J.
    Keating, Thomas A.
    MOLECULAR PHARMACEUTICS, 2020, 17 (01) : 50 - 58
  • [30] Antibody-drug conjugates with DNA inhibitor linker-payloads can overcome resistance in cultured tumor cells made resistant to conjugates with cleavable-linked auristatins
    Tan, Xingzhi
    Sung, Matthew
    Loganzo, Frank
    CANCER RESEARCH, 2018, 78 (13)